Skip to content

Revaluation of Wells' Clinical Prediction Score of Deep Vein Thrombosis (DVT) in Inpatients With Thromboprophylaxis Treatment

R-WITT Study : Revaluation of Wells' Clinical Prediction Score in Inpatients With Thromboprophylaxis Treatment

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03784937
Acronym
R-WITT
Enrollment
415
Registered
2018-12-24
Start date
2018-02-01
Completion date
2019-03-04
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep Vein Thrombosis, Thromboses, Venous

Keywords

Wells Clinical score, Thromboprophylaxis

Brief summary

This study aimed (1) revaluating the efficacy of the Wells' clinical prediction score for an inpatient population; and the weight of the presence of thromboprophylaxis treatment on the score, and (2) evaluating the correlation of a risk stratification established between a physician specialised in thrombosis and any other doctor.

Interventions

DIAGNOSTIC_TESTDoppler ultrasound

Each patient received Doppler ultrasound for research of DVT, no matter the risk stratification.

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any patient addressed to an Vascular Medicine unit for a clinical suspicion of DVT, with risk stratification through the modified Wells score by the referent doctor.

Exclusion criteria

* Patient addressed to our Vascular Medicine unit for any other reason. * Patient addressed to our Vascular Medicine unit for DVT detection to help in a pulmonary embolism suspicion. * Age under 18 yo * Patients unable to express their informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Performance of the Wells Clinical prediction scoreFor enrollment to end of enrollment at 12 monthsAnalyse area under the curve (AUC) of the Wells' score ROC (Receiver Operating Characteristic) curve for an inpatient population

Secondary

MeasureTime frameDescription
Impact of thromboprophylaxis treatmentFor enrollment to end of enrollment at 12 monthsCompare area under curve of ROC curves of Wells' score between an inpatient population with or without thromboprophylaxis treatment
Coherency of Wells' score between an doctor specialized in thrombosis and any other doctor.For enrollment to end of enrollment at 12 monthsCompare Area under curve for ROC curves of Wells' score between an doctor specialized in thrombosis and any other doctor.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026